MJFF’s Innovative, New Funding Program Addresses the Entire Therapeutics Pipeline
Did you know that the Michael J. Fox Foundation for Parkinson’s Research funds industry?
The Michael J. Fox Foundation (MJFF) is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today.
The MJFF is committed to sharing the risk of drug development with researchers from academia and industry in order to keep promising research moving forward along this important pipeline. To date, we have funded over $297 million in research, $77 million of which has been awarded to more than 160 unique, industry-led projects.
BayBio encourages the Bay Area’s Parkinson’s and central nervous system research communitiesto participate in the newest MJFF funding mechanism, the Therapeutic Pipeline Program (TPP) (read the announcement here). This program combines MJFF’s previous Therapeutics Development Initiative (TDI), Repositioning Drugs for PD, and Clinical Intervention Awards (CIA) programs into a single, streamlined funding opportunity.
The TPP seeks to support research projects along the entire drug development pipeline and is open to both industry and academic investigators.This comprehensive approach to funding encourages investigators to think holistically about the path towards therapeutic development, regardless of the current stage of their research.
MJFF will commit up to $10 million to TPP with the intention of supporting multiple awards.TPP will be launched annually with a two-stage review process, and Stage I Proposals are due September 12, 2012 by 6:00 pm ET. To apply for the Therapeutics Pipeline Program, please visit https://www.michaeljfox.org/research/grant-detail.php?id=9.
To further explain the goals of this funding initiative and to answer applicant questions, MJFF held an informational conference call on August 1st. If you missed the call, a recording and transcription of what was covered, as well as more information about the program, are available on the TPP Web page.